Stock ALT ALTIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Estimates Revisions Altimmune, Inc.

Equities

ALT

US02155H2004

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-09-16 EDT 		5-day change 1st Jan Change
7.580 USD -3.81% Intraday chart for Altimmune, Inc. +18.81% -32.62%
09-10 Sector Update: Health Care Stocks Advance Late Afternoon MT
09-10 Altimmune Shares Jump After Pemvidutide Shows Strong Lean Mass Preservation in Obesity Trial MT

Turnover - Evolution of Analysts' Estimates

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

EBIT - Evolution of Analysts' Estimates

Cash or Net Debt - Evolution of Analysts' Estimates

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 1m. EPS revision 1m. Revenue rev. 1y. EPS revision 1y. Revenue rev.
ALTIMMUNE, INC. Stock Altimmune, Inc.
 -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
ARGENX SE Stock argenx SE
BIONTECH SE Stock BioNTech SE
BEIGENE, LTD. Stock BeiGene, Ltd.
GENMAB A/S Stock Genmab A/S
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
VAXCYTE, INC. Stock Vaxcyte, Inc.
 - -
Average
Weighted average by Cap.
See all sector revisions

Turnover

Estimates Revisions:

Earnings Per Share (EPS)

Estimates Revisions:

EBIT

Estimates Revisions:

Cash or Net Debt

Estimates Revisions:
  1. Stock Market
  2. Equities
  3. ALT Stock
  4. Consensus Altimmune, Inc.
  5. Estimates Revisions
-40% Exceptional Extension: Our subscriptions help you unlock hidden opportunities. Exceptional extension!
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition